After One Year, Popular Weight Loss Drug Semaglutide (Wegovy/Ozempic) Improved Heart Health

A small study found that the popular weight loss drug semaglutide may help lower the risk of developing cardiovascular disease. After one year, study participants showed improvements in multiple cardiovascular risk factors, including blood pressure,...

May 23, 2023 Today's top story After One Year, Popular Weight Loss Drug Semaglutide (Wegovy/Ozempic) Improved Heart Health A small study found that the popular weight loss drug semaglutide may help lower the risk of developing cardiovascular disease. After one year, study participants showed improvements in multiple cardiovascular risk factors, including blood pressure,... Read on       Psoriatic Arthritis Medication Brepocitinib Reduced Symptoms by 20% in Phase 2 Trial Read ON   How a Breakthrough Treatment Helped 'Cure' This Man of HIV Read ON   Genetic Tendency Toward Higher Blood Pressure and Cholesterol May Increase Alzheimer's Risk, Study Suggests Read ON   More top Reads       Advertisement Start a custom weight loss program Noom helps you adopt healthy habits so you can lose weight and keep it off. GET STARTED

View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy  |  Unsubscribe Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health. © 2023 Healthline Media LLC 275 7th Ave., 24th Floor New York, NY 10001